These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 34082503)

  • 1.
    Gündoğan C; Ergül N; Çakır MS; Kılıçkesmez Ö; Gürsu RU; Aksoy T; Çermik TF
    Mol Imaging Radionucl Ther; 2021 Jun; 30(2):79-85. PubMed ID: 34082503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Kesler M; Levine C; Hershkovitz D; Mishani E; Menachem Y; Lerman H; Zohar Y; Shibolet O; Even-Sapir E
    J Nucl Med; 2019 Feb; 60(2):185-191. PubMed ID: 30002112
    [No Abstract]   [Full Text] [Related]  

  • 4. PET/CT using
    Liu D; Cheng G; Ma X; Wang S; Zhao X; Zhang W; Yang W; Wang J
    J Neuroimaging; 2021 Jul; 31(4):733-742. PubMed ID: 34021667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The roles of 68 Ga-PSMA PET/CT and 18 F-FDG PET/CT imaging in patients with triple-negative breast cancer and the association of tissue PSMA and claudin 1, 4, and 7 levels with PET findings.
    Arslan E; Ergül N; Beyhan E; Erol Fenercioglu Ö; Sahin R; Cin M; Battal Havare S; Can Trabulus FD; Mermut Ö; Akbas S; Fikret Çermik T
    Nucl Med Commun; 2023 Apr; 44(4):284-290. PubMed ID: 36756767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence of Prostate-Specific Membrane Antigen Expression in Hepatocellular Carcinoma Using 68Ga-PSMA PET/CT.
    Kuyumcu S; Has-Simsek D; Iliaz R; Sanli Y; Buyukkaya F; Akyuz F; Turkmen C
    Clin Nucl Med; 2019 Sep; 44(9):702-706. PubMed ID: 31348076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative Findings Between
    Erhamamcı S; Aslan N
    Mol Imaging Radionucl Ther; 2020 Oct; 29(3):135-138. PubMed ID: 33094578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of
    Shi Y; Xu L; Zhu Y; Wang Y; Chen R; Liu J
    Front Oncol; 2021; 11():646110. PubMed ID: 33777806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic Value of 68Ga PSMA-11 PET/CT Imaging of Brain Tumors-Preliminary Analysis.
    Sasikumar A; Joy A; Pillai MR; Nanabala R; Anees K M; Jayaprakash PG; Madhavan J; Nair S
    Clin Nucl Med; 2017 Jan; 42(1):e41-e48. PubMed ID: 27846000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective investigation of amino acid transport and PSMA-targeted positron emission tomography for metastatic lobular breast carcinoma.
    Mushtaq A; Lawal IO; Muzahir S; Friend SC; Bhave M; Meisel JL; Torres MA; Styblo TM; Graham CL; Kalinsky K; Switchenko J; Ulaner GA; Schuster DM
    Eur J Nucl Med Mol Imaging; 2024 Nov; 51(13):4073-4082. PubMed ID: 38976035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differentiating benign and malignant pancreatic masses: Ga-68 PSMA PET/CT as a new diagnostic avenue.
    Krishnaraju VS; Kumar R; Mittal BR; Sharma V; Singh H; Nada R; Bal A; Rohilla M; Singh H; Rana SS
    Eur Radiol; 2021 Apr; 31(4):2199-2208. PubMed ID: 33001304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [
    Lin R; Wang C; Chen S; Lin T; Cai H; Chen S; Yang Y; Zhang J; Xu F; Zhang J; Chen X; Zang J; Miao W
    Eur J Nucl Med Mol Imaging; 2024 Jan; 51(2):535-547. PubMed ID: 37728667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary Hepatocellular Carcinoma With Intense 68Ga-PSMA Uptake But Slight 18F-FDG Uptake on PET/CT Imaging.
    Erhamamci S; Aslan N
    Clin Nucl Med; 2020 Mar; 45(3):e176-e177. PubMed ID: 31977478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Head-to-head comparison of [
    Souza SPM; Frasson FC; Takahashi MES; Duarte GBO; Castro VP; Pericole FV; Velloso LA; De Souza CA; Lorand-Metze I; Santos AO; Ramos CD
    Eur J Nucl Med Mol Imaging; 2023 Jul; 50(8):2432-2440. PubMed ID: 36988710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic Performance of [
    Paymani Z; Rohringer T; Vali R; Loidl W; Alemohammad N; Geinitz H; Langsteger W; Beheshti M
    J Clin Med; 2020 Jul; 9(7):. PubMed ID: 32708097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Head-to-head comparisons of
    Lin BH; Chen SH; Chen SM; Qiu QR; Gao RC; Wei Y; Zheng QS; Miao WB; Xu N
    Int Urol Nephrol; 2023 Nov; 55(11):2753-2764. PubMed ID: 37477778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostate-Specific Membrane Antigen in Anaplastic and Poorly Differentiated Thyroid Cancer-A New Diagnostic and Therapeutic Target?
    Wächter S; Di Fazio P; Maurer E; Manoharan J; Keber C; Pfestroff A; Librizzi D; Bartsch DK; Luster M; Eilsberger F
    Cancers (Basel); 2021 Nov; 13(22):. PubMed ID: 34830843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The risk of prostate cancer on incidental finding of an avid prostate uptake on 2-deoxy-2-[
    Franklin A; Gianduzzo T; Kua B; Wong D; McEwan L; Walters J; Esler R; Roberts MJ; Coughlin G; Yaxley JW
    Asian J Urol; 2024 Jan; 11(1):33-41. PubMed ID: 38312828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A pilot study of
    Wang G; Zhou M; Zang J; Jiang Y; Chen X; Zhu Z; Chen X
    EJNMMI Res; 2022 Aug; 12(1):52. PubMed ID: 35984529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MIB-1 Index-Stratified Assessment of Dual-Tracer PET/CT with
    Sampathirao N; Basu S
    J Nucl Med Technol; 2017 Mar; 45(1):34-41. PubMed ID: 28154019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.